Improved synthesis of 3, 4- bis (phenylsulfonyl)- 1,2,5-oxadizole-2-oxide

Journal of China Pharmaceutical University

Volumn 33, Issue 6, 2002, Pages 548-549

  Xu, Xin ^a   Wang, Wei Dong ^a   Zhang, Yi Hua ^a   Peng, Si Xun ^a   Yang, Qun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3,4 Bis(phenylsulfonyl) 1,2,5 oxadizazole 2 oxide; NO donor; Synthesis

Indexed keywords

3,4 BIS(PHENYLSULFONYL) 1,2,5 OXADIZOLE 2 OXIDE; OXADIAZOLE DERIVATIVE; THIOPHENOL; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; OXIDATION;

EID: 30044432545     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hou YC,Jancznk A,Wang PG. Current trends in the development of nitric oxide donors[J]. Curr Pharm Design, 1999,5:417-441.
2. Sorba G,Medana C,Fruttero R, et al. Water soluble furoxan derivatives as NO prodrugs[J]. J Med Chem, 1997,40(4):463-469.
3. Stico AD, Visentin S, Cena C, et al. New 1, 4-dihydropyridines conjugated to Furoxanyl moiety, endowed with nitric oxide- like and calcium channel antagonist vasodilator activities[J]. J Med Chem, 1998,41(27):5393-5401.
4. Li RW, Zhang YH, Ji H. Acta Pharm Sin, 2001,36(11):821-825.
5. Li RW, Zhang YH, Ji H. Acta Pharm Sin, 2002,37(1):27-32.